Skip to content

CLEMENT PHARMA SERVICES: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CLEMENT PHARMA SERVICES

BE 0886.394.314
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,603
2024 · -€1,304+€4,907
Equity
€108,811
2024 · €154,811-€46,000
Cash
€24,437
2024 · €32,430-€7,993
Balance sheet total
€151,301
2024 · €176,112-€24,811

Largest movements

2024 to 2025
Assets
  • Receivables after one year -€30,661

    down €30,661 (-39.7%), from €77,234 to €46,573

  • Current investments +€16,882

    up €16,882 (+201.0%), from €8,400 to €25,282

  • Cash -€7,993

    down €7,993 (-24.6%), from €32,430 to €24,437

    mainly Contributions, distributions and other (-€49,603) and Current investments (-€16,882)

  • Tangible fixed assets -€7,511

    down €7,511 (-29.2%), from €25,767 to €18,256

    of which Furniture and vehicles: -€7,279

  • Receivables within one year +€4,431

    up €4,431 (+15.2%), from €29,118 to €33,548

    of which Other amounts receivable: +€11,675

Equity and liabilities
  • Reserves -€46,244

    down €46,244 (-32.4%), from €142,654 to €96,411

  • Other debts +€26,529

    up €26,529, from €0 to €26,529

  • Debts after one year -€8,313

    down €8,313 (-92.3%), from €9,010 to €696

  • Tax, wage and social debts +€3,060

    up €3,060 (+135.1%), from €2,265 to €5,325

Income statement
  • Gross operating margin +€9,985

    up €9,985 (+330.4%), from €3,022 to €13,007

  • Depreciation +€2,184

    up €2,184 (+41.0%), from €5,328 to €7,511

  • Financial income -€1,747

    down €1,747 (-58.9%), from €2,969 to €1,221

  • Taxes +€1,263

    up €1,263 (+196.0%), from €645 to €1,908

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€1,304
Gross operating margin +€9,985
Depreciation -€2,184
Other operating charges +€44
Financial income -€1,747
Financial charges +€72
Taxes -€1,263
Result 2025 €3,603

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€66,724
Investment -€16,882
Financing -€57,835
Cash 2024 €32,430
Net result for the year +€3,603
Depreciation +€7,511
Receivables after one year +€30,661
Receivables within one year -€4,431
Deferred charges and accrued income -€41
Trade debts -€168
Tax, wage and social debts +€3,060
Other debts +€26,529
Current investments -€16,882
Debts after one year -€8,313
Current portion of long-term debt +€81
Contributions, distributions and other -€49,603
Cash 2025 €24,437
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €176,112 €151,301 -€24,811 -14.1%
Fixed assets 21/28 €25,767 €18,256 -€7,511 -29.2%
Tangible fixed assets 22/27 €25,767 €18,256 -€7,511 -29.2%
Plant, machinery and equipment 23 €458 €226 -€232 -50.7%
Furniture and vehicles 24 €25,308 €18,030 -€7,279 -28.8%
Current assets 29/58 €150,345 €133,045 -€17,300 -11.5%
Amounts receivable after more than one year 29 €77,234 €46,573 -€30,661 -39.7%
Other amounts receivable 291 €77,234 €46,573 -€30,661 -39.7%
Amounts receivable within one year 40/41 €29,118 €33,548 +€4,431 +15.2%
Trade receivables 40 €16,114 €8,869 -€7,244 -45.0%
Other amounts receivable 41 €13,004 €24,679 +€11,675 +89.8%
Current investments 50/53 €8,400 €25,282 +€16,882 +201.0%
Cash at bank and in hand 54/58 €32,430 €24,437 -€7,993 -24.6%
Deferred charges and accrued income 490/1 €3,164 €3,205 +€41 +1.3%
Total equity and liabilities 10/49 €176,112 €151,301 -€24,811 -14.1%
Equity 10/15 €154,811 €108,811 -€46,000 -29.7%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €142,654 €96,411 -€46,244 -32.4%
Distributable reserves 133 €142,654 €96,411 -€46,244 -32.4%
Profit (loss) carried forward 14 -€244 €0 +€244
Amounts payable 17/49 €21,301 €42,490 +€21,189 +99.5%
Amounts payable after more than one year 17 €9,010 €696 -€8,313 -92.3%
Financial debts 170/4 €9,010 €696 -€8,313 -92.3%
Amounts payable within one year 42/48 €12,291 €41,794 +€29,502 +240.0%
Current portion of amounts payable after more than one year 42 €8,232 €8,313 +€81 +1.0%
Trade debts 44 €1,794 €1,626 -€168 -9.4%
Suppliers 440/4 €1,794 €1,626 -€168 -9.4%
Taxes, remuneration and social security 45 €2,265 €5,325 +€3,060 +135.1%
Taxes 450/3 €2,265 €5,325 +€3,060 +135.1%
Other amounts payable 47/48 €0 €26,529 +€26,529
Accrued charges and deferred income 492/3 €0 - =
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,328 €7,511 +€2,184 +41.0%
Other operating charges 640/8 €955 €911 -€44 -4.6%
Gross operating margin 9900 €3,022 €13,007 +€9,985 +330.4%
Operating profit (loss) 9901 -€3,261 €4,585 +€7,845
Financial income 75/76B €2,969 €1,221 -€1,747 -58.9%
Recurring financial income 75 €2,969 €1,221 -€1,747 -58.9%
Financial charges 65/66B €367 €296 -€72 -19.5%
Recurring financial charges 65 €367 €296 -€72 -19.5%
Profit (loss) for the period before taxes 9903 -€659 €5,510 +€6,170
Income taxes 67/77 €645 €1,908 +€1,263 +196.0%
Profit (loss) for the period 9904 -€1,304 €3,603 +€4,907
Profit (loss) for the period to be appropriated 9905 -€1,304 €3,603 +€4,907

Source: filed annual accounts (NBB), fiscal years ended 30 November 2024 and 30 November 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.